Drugmaker Eli Lilly said Tuesday it is pausing its trial of a combination antibody treatment for coronavirus for safety reasons.Usually, clinical trials are paused because a volunteer has suffered a side effect or become ill, but the company did not say what happened.”Safety is of the (utmost) importance to Lilly,” a spokesperson told CNN by email.It said the trial’s Data Safety Monitoring Board (DSMB), an